Protein Science, Vol 7, Issue 8 1681-1690, Copyright © 1998 by Cold Spring Harbor Laboratory Press

ARTICLE

Correlation between the 1.6 A crystal structure and mutational analysis of Keratinocyte Growth Factor

T. D. OSSLUND, R. SYED, E. SINGER, EWJ. HSU, R. NYBO, B. L. CHEN, T. HARVEY, T. ARAKAWA, L. O. NARHI, A. CHIRINO and C. F. MORRIS
Amgen, Amgen Center, Thousand Oaks, California, 91320-1789

A comprehensive deletion, mutational, and structural analysis of the native recombinant keratinocyte growth factor (KGF) polypeptide has resulted in the identification of the amino acids responsible for its biological activity. One of these KGF mutants ({Delta}23KGF-R144Q) has biological activity comparable to the native protein, and its crystal structure was determined by the multiple isomorphous replacement plus anomalous scattering method (MIRAS). The structure of KGF reveals that it folds into a {beta}-trefoil motif similar to other members of fibroblast growth factor (FGF) family whose structures have been resolved. This fold consists of 12 anti-parallel {beta}-strands in which three pairs of the strands form a six-stranded beta-barrel structure and the other three pairs of {beta}-strands cap the barrel with hairpin triplets forming a triangular array. KGF has 10 well-defined beta strands, which form five double-stranded anti-parallel beta-sheets. A sixth poorly defined {beta}-strand pair is in the loop between residues 133 and 144, and is defined by only a single hydrogen bond between the two strands. The KGF mutant has 10 additional ordered amino terminus residues (24-33) compared to the other FGF structures, which are important for biological activity. Based on mutagenesis, thermal stability, and structural data we postulate that residues TRP125, THR126, and His127 predominantly confer receptor binding specificity to KGF. Additionally, residues GLN152, GLN138, and THR42 are implicated in heparin binding. The increased thermal stability of {Delta}23KGF-R144Q can structurally be explained by the additional formation of hydrogen bonds between the GLN side chain and a main-chain carbonyl on an adjoining loop. The correlation of the structure and biochemistry of KGF provides a framework for a rational design of this potentially important human therapeutic.
CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J.-B. Jomain, E. Tallet, I. Broutin, S. Hoos, J. van Agthoven, A. Ducruix, P. A. Kelly, B. B. Kragelund, P. England, and V. Goffin Structural and Thermodynamic Bases for the Design of Pure Prolactin Receptor Antagonists: X-RAY STRUCTURE OF Del1-9-G129R-hPRL J. Biol. Chem., November 9, 2007; 282(45): 33118 - 33131. [Abstract] [Full Text] [PDF]

				T. S. Lendvay, R. Sweet, C.-H. Han, T. Soygur, J.-F. Cheng, J. C. Plaire, J. S. Charleston, L. B. Charleston, S. Bagai, K. Cochrane, et al. Compensatory paracrine mechanisms that define the urothelial response to injury in partial bladder outlet obstruction Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1147 - F1156. [Abstract] [Full Text] [PDF]

				E. Hsu, T. Osslund, R. Nybo, B.-L. Chen, W. C. Kenney, C.F. Morris, T. Arakawa, and L. O. Narhi Enhanced stability of recombinant keratinocyte growth factor by mutagenesis Protein Eng. Des. Sel., April 1, 2006; 19(4): 147 - 153. [Abstract] [Full Text] [PDF]

				O. A. Ibrahimi, F. Zhang, A. V. Eliseenkova, N. Itoh, R. J. Linhardt, and M. Mohammadi Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities Hum. Mol. Genet., October 1, 2004; 13(19): 2313 - 2324. [Abstract] [Full Text] [PDF]

				S. K. Olsen, M. Garbi, N. Zampieri, A. V. Eliseenkova, D. M. Ornitz, M. Goldfarb, and M. Mohammadi Fibroblast Growth Factor (FGF) Homologous Factors Share Structural but Not Functional Homology with FGFs J. Biol. Chem., September 5, 2003; 278(36): 34226 - 34236. [Abstract] [Full Text] [PDF]

				B. K. Yeh, M. Igarashi, A. V. Eliseenkova, A. N. Plotnikov, I. Sher, D. Ron, S. A. Aaronson, and M. Mohammadi Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors PNAS, March 4, 2003; 100(5): 2266 - 2271. [Abstract] [Full Text] [PDF]

				M. Goldfarb Signaling By Fibroblast Growth Factors: The Inside Story Sci. Signal., October 30, 2001; 2001(106): pe37 - pe37. [Abstract] [Full Text] [PDF]

				P. Bellosta, A. Iwahori, A. N. Plotnikov, A. V. Eliseenkova, C. Basilico, and M. Mohammadi Identification of Receptor and Heparin Binding Sites in Fibroblast Growth Factor 4 by Structure-Based Mutagenesis Mol. Cell. Biol., September 1, 2001; 21(17): 5946 - 5957. [Abstract] [Full Text] [PDF]

				I. Sher, A. Weizman, S. Lubinsky-Mink, T. Lang, N. Adir, D. Schomburg, and D. Ron Mutations Uncouple Human Fibroblast Growth Factor (FGF)-7 Biological Activity and Receptor Binding and Support Broad Specificity in the Secondary Receptor Binding Site of FGFs J. Biol. Chem., December 3, 1999; 274(49): 35016 - 35022. [Abstract] [Full Text] [PDF]

				I. Sher, T. Lang, S. Lubinsky-Mink, J. Kuhn, N. Adir, S. Chatterjee, D. Schomburg, and D. Ron Identification of Residues Important Both for Primary Receptor Binding and Specificity in Fibroblast Growth Factor-7 J. Biol. Chem., November 3, 2000; 275(45): 34881 - 34886. [Abstract] [Full Text] [PDF]

				A. N. Plotnikov, A. V. Eliseenkova, O. A. Ibrahimi, Z. Shriver, R. Sasisekharan, M. A. Lemmon, and M. Mohammadi Crystal Structure of Fibroblast Growth Factor 9 Reveals Regions Implicated in Dimerization and Autoinhibition J. Biol. Chem., February 2, 2001; 276(6): 4322 - 4329. [Abstract] [Full Text] [PDF]